Astrana Health (NASDAQ:ASTH) Shares Up 3.9% – What’s Next?

Astrana Health, Inc. (NASDAQ:ASTH) shot up 3.9% on Tuesday . The stock traded as high as $31.66 and last traded at $31.81. 130,682 shares traded hands during mid-day trading, a decline of 48% from the average session volume of 249,187 shares. The stock had previously closed at $30.60.

Wall Street Analyst Weigh In

Several research firms have weighed in on ASTH. Robert W. Baird dropped their price objective on Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a report on Monday, March 3rd. Stifel Nicolaus lowered their target price on Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a research note on Thursday, February 20th. Bank of America lowered their target price on Astrana Health from $55.00 to $49.00 and set a “buy” rating for the company in a research note on Tuesday, March 4th. Truist Financial lowered their target price on Astrana Health from $50.00 to $46.00 and set a “buy” rating for the company in a research note on Tuesday. Finally, Macquarie upgraded Astrana Health to a “hold” rating in a research note on Monday, December 16th. Two equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $56.17.

Astrana Health Trading Up 5.1 %

The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. The company has a market cap of $1.81 billion, a P/E ratio of 24.73, a price-to-earnings-growth ratio of 1.37 and a beta of 1.30. The stock has a 50-day moving average of $33.95 and a two-hundred day moving average of $42.95.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The company had revenue of $665.21 million for the quarter, compared to the consensus estimate of $617.24 million. On average, equities research analysts predict that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Institutional Trading of Astrana Health

A number of institutional investors and hedge funds have recently modified their holdings of ASTH. State Street Corp bought a new stake in shares of Astrana Health in the 3rd quarter worth $91,966,000. Geode Capital Management LLC bought a new stake in shares of Astrana Health in the 3rd quarter worth $58,995,000. FMR LLC bought a new stake in shares of Astrana Health in the 3rd quarter worth $48,413,000. Loomis Sayles & Co. L P bought a new stake in shares of Astrana Health in the 3rd quarter worth $30,251,000. Finally, Charles Schwab Investment Management Inc. bought a new stake in shares of Astrana Health in the 3rd quarter worth $25,945,000. Institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.